Skip to main content
SpringerLink
Log in

Sirolimus may raise risk of post-liver transplant CVD, death

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Doycheva IB, Couto CA, Gelape CL, Kish JK, Martin P, Levy C.Immunosuppression with Sirolimus increases cardiovascular risk in liver transplant recipients. 47th Annual Meeting of the European Association for the Study of the Liver: abstr. 191, 18 Apr 2012. Available from: URL: http://mobile.ilcapp.eu/easl%5f161/poster%5f23366/program.aspx

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirolimus may raise risk of post-liver transplant CVD, death. React. Wkly. 1406, 3 (2012). https://doi.org/10.2165/00128415-201214060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214060-00007

Keywords

Search

Navigation